Hybrid Ablation demonstrates over 80% effectiveness at 1-year in reducing recurring atrial arrhythmias* in patients with LSPAF, per the TRAC-AF Registry. Real-world results align with CONVERGE Trial data.
Registry: <a href="https://t.co/ewvRrO27BZ" target="_blank">https://t.co/ewvRrO27BZ</a>
<a href="https://twitter.com/hashtag/HybridAblation?src=hashtag_click" target="_blank">#HybridAblation</a>